During Christmas week 2015, doctors determined that Dr. Robert Bolding had a terminal aggressive tumor, a GBM or Glioblastoma Multiforme, growing in the right side of his brain. The right hemisphere processes music. He was given only a few months to live. Dr. Bob had only a few warning signs that something might be wrong. He thought it was possible that he had perhaps had a stroke. He had numbness on his left side and his family said his behavior was odd. Bob was inclined to ignore the headaches he had been having, he figured maybe it was the weather. Bob is not one to worry. But there was one thing deep down that was bothering him, it was the fact that he was not able to sing and he didn’t know why. That was the symptom he noticed that got his attention. The typical survival rate for glioblastoma multiforme, an aggressive type of brain cancer, is 15 to 17 months, but new types of treatment designed to battle the tumors have been shown to extend survival rates by years. According to the American Brain Tumor Association more than 12,000 new cases of glioblastoma are diagnosed in the US each year, and recently the aggressive brain tumor was discovered in Sen. John McCain. After going through brain surgery, radiation, chemotherapy, Bob started fighting his Glioblastoma, the deadliest form of brain tumor, with a relatively new therapy called an Optune cap. For 20 or more hours a day, he wore an electrode cap and a backpack that delivers an intermediate-frequency alternating electric field to his brain. So many people always surrounded Bob in his life. Since he was diagnosed he was able to walk his daughter down the isle and he got to meet his grandchildren. On May 26, 2018 – 2 1/2 years after his diagnosis Dr Bob passed away peacefully.. surrounded by the people he loved most.